Claire L O’Reilly
Biographic Data
| ID | 6478872 |
|---|---|
| NAME | Claire L O’Reilly |
| GIVEN NAMES | Claire L |
| FAMILY NAME | O’Reilly |
| SIGNATURE | O’REILLY C L |
| AFFILIATIONS | The University of Sydney |
| ORCID | 0000-0001-6416-8150 |
| VERIFIED | Yes |
| TOTAL WORKS | 13 |
| TOTAL CITATIONS | 4 |
| WORKS AS AUTHOR | 13 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2010 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Caregivers’ Perspectives Regarding the Use of Psychotropic Medication in Children and Young Adults
Side Effects of Psychotropic Medications Experienced by a Community Sample of People Living With Severe and Persistent Mental Illness
BACKGROUND: Psychotropic medications are a common treatment modality for people living with severe and persistent mental illness (SPMI). While effective in reducing relapse and hospitalisation, psychotropic medications cause numerous side effects, varying in nature and severity. Identification and management of side effects is crucial in the ongoing management of SPMI. OBJECTIVE: To characterise the side effects of psychotropic medications, exper…
Experiences of goal planning in Australian community pharmacy settings for people experiencing mental illness
BACKGROUND: Person-centred goal planning is increasingly being incorporated into healthcare interventions. People experiencing severe and persistent mental illnesses (SPMIs) have high levels of co-occurring health conditions, reducing their life expectancy when compared with the general population. As medications are commonly used in the treatment of SPMIs, community pharmacists are well-placed to support the health and wellbeing of this populati…
Psychological distress in community-dwelling individuals living with severe and persistent mental illness
OBJECTIVES: To explore psychological distress levels, using the validated Kessler 6 (K6), as well as the relationship between demographics and K6 scores, and incidence of mental health crises in a cohort of community-dwelling people living with severe and persistent mental illness (SPMI). METHODS: People living with SPMI taking antipsychotic or mood stabiliser medications were recruited from Australian community pharmacies between September 2020 …
Healthcare professionals’ knowledge, confidence and attitudes in relation to psychosis care
A training programme for community pharmacists to support people living with severe and persistent mental illness
Objective: The Bridging the Gap Between Physical and Mental Illness in Community Pharmacy ( PharMIbridge) randomised controlled trial (RCT) aims to test the effectiveness of a pharmacist-led support service in improving medication adherence, and the physical and mental health of people living with severe and persistent mental illness compared to a standard medication review service. Method: Using the six-step intervention mapping (IM) framework, …
Perinatal Women’s Views of Pharmacist-Delivered Perinatal Depression Screening
Internationally, 20% of women experience perinatal depression (PND). Healthcare providers including general practitioners and midwives are critical in providing PND screening and support; however, the current workforce is unable to meet growing demands for PND care. As accessible and trusted primary healthcare professionals, pharmacists could provide PND care to complement existing services, thereby contributing to early detection and interventio…
Confirmatory Factor Analysis of the Kessler-6 Psychological Distress (K6) Scale in a Community Sample of People Living with Severe and Persistent Mental Illness
Stigma and discrimination in individuals with severe and persistent mental illness in an assertive community treatment team
AIM: To explore family member and staff perceptions of clients' experiences of stigma and discrimination, in those living with severe and persistent mental illness in an Assertive Community Treatment Team. METHOD: This qualitative study used the Discrimination and Stigma Scale to conduct structured face-to-face and telephone interviews of family members and healthcare professionals, working with the Assertive Outreach Team (AOT) (an Assertive Com…
The role of community pharmacists in the identification and ongoing management of women at risk for perinatal depression
BACKGROUND: While pharmacists are among the most accessible primary health professionals within a mother's healthcare team to identify potential cases of perinatal depression (PND), very little in the literature suggests that this role has been explored. AIM: The aim of this study was to explore community pharmacists' perspectives on their potential roles in perinatal mental health promotion (recognition and health education) and the factors affe…
Evidence for effective interventions to reduce mental-health-related stigma and discrimination
Stigma and discrimination experienced by people living with severe and persistent mental illness in assertive community treatment settings
AIMS: To describe the perceived experiences of stigma and discrimination among people living with severe and persistent mental illness in assertive community treatment (ACT teams) settings in New South Wales (NSW), Australia. METHODS: The Discrimination and Stigma Scale (DISC) was used in this cross-sectional study with people living with severe and persistent mental illness. The DISC is a reliable and valid, quantitative and qualitative instrume…
Auslandsaufenthalte in Schule und Studium
Auslandsaufenthalte in Schule und Studium
Evidence for effective interventions to reduce mental-health-related stigma and discrimination
Stigma and discrimination experienced by people living with severe and persistent mental illness in assertive community treatment settings
AIMS: To describe the perceived experiences of stigma and discrimination among people living with severe and persistent mental illness in assertive community treatment (ACT teams) settings in New South Wales (NSW), Australia. METHODS: The Discrimination and Stigma Scale (DISC) was used in this cross-sectional study with people living with severe and persistent mental illness. The DISC is a reliable and valid, quantitative and qualitative instrume…
The role of community pharmacists in the identification and ongoing management of women at risk for perinatal depression
BACKGROUND: While pharmacists are among the most accessible primary health professionals within a mother's healthcare team to identify potential cases of perinatal depression (PND), very little in the literature suggests that this role has been explored. AIM: The aim of this study was to explore community pharmacists' perspectives on their potential roles in perinatal mental health promotion (recognition and health education) and the factors affe…
Stigma and discrimination in individuals with severe and persistent mental illness in an assertive community treatment team
AIM: To explore family member and staff perceptions of clients' experiences of stigma and discrimination, in those living with severe and persistent mental illness in an Assertive Community Treatment Team. METHOD: This qualitative study used the Discrimination and Stigma Scale to conduct structured face-to-face and telephone interviews of family members and healthcare professionals, working with the Assertive Outreach Team (AOT) (an Assertive Com…
A training programme for community pharmacists to support people living with severe and persistent mental illness
Objective: The Bridging the Gap Between Physical and Mental Illness in Community Pharmacy ( PharMIbridge) randomised controlled trial (RCT) aims to test the effectiveness of a pharmacist-led support service in improving medication adherence, and the physical and mental health of people living with severe and persistent mental illness compared to a standard medication review service. Method: Using the six-step intervention mapping (IM) framework, …
Perinatal Women’s Views of Pharmacist-Delivered Perinatal Depression Screening
Internationally, 20% of women experience perinatal depression (PND). Healthcare providers including general practitioners and midwives are critical in providing PND screening and support; however, the current workforce is unable to meet growing demands for PND care. As accessible and trusted primary healthcare professionals, pharmacists could provide PND care to complement existing services, thereby contributing to early detection and interventio…
Confirmatory Factor Analysis of the Kessler-6 Psychological Distress (K6) Scale in a Community Sample of People Living with Severe and Persistent Mental Illness
Experiences of goal planning in Australian community pharmacy settings for people experiencing mental illness
BACKGROUND: Person-centred goal planning is increasingly being incorporated into healthcare interventions. People experiencing severe and persistent mental illnesses (SPMIs) have high levels of co-occurring health conditions, reducing their life expectancy when compared with the general population. As medications are commonly used in the treatment of SPMIs, community pharmacists are well-placed to support the health and wellbeing of this populati…
Psychological distress in community-dwelling individuals living with severe and persistent mental illness
OBJECTIVES: To explore psychological distress levels, using the validated Kessler 6 (K6), as well as the relationship between demographics and K6 scores, and incidence of mental health crises in a cohort of community-dwelling people living with severe and persistent mental illness (SPMI). METHODS: People living with SPMI taking antipsychotic or mood stabiliser medications were recruited from Australian community pharmacies between September 2020 …
Healthcare professionals’ knowledge, confidence and attitudes in relation to psychosis care
Side Effects of Psychotropic Medications Experienced by a Community Sample of People Living With Severe and Persistent Mental Illness
BACKGROUND: Psychotropic medications are a common treatment modality for people living with severe and persistent mental illness (SPMI). While effective in reducing relapse and hospitalisation, psychotropic medications cause numerous side effects, varying in nature and severity. Identification and management of side effects is crucial in the ongoing management of SPMI. OBJECTIVE: To characterise the side effects of psychotropic medications, exper…
Caregivers’ Perspectives Regarding the Use of Psychotropic Medication in Children and Young Adults
Medicine (10 works) · Psychiatry (9 works) · Psychology (9 works) · Mental health (7 works) · Clinical Psychology (6 works) · Mental Health Treatment and Access (6 works) · Mental illness (6 works) · Schizophrenia research and treatment (6 works) · Nursing (4 works) · Qualitative research (4 works)